Journal Article

CANCER BIOLOGY: Type II TGFβ receptor expression in intestinal cell lines and in the intestinal tract

Michele P. Winesett, Ginger W. Ramsey and John A. Barnard

in Carcinogenesis

Volume 17, issue 5, pages 989-995
Published in print May 1996 | ISSN: 0143-3334
e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/17.5.989
CANCER BIOLOGY: Type II TGFβ receptor expression in intestinal cell lines and in the intestinal tract

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

The recent identification and cloning of mammalian transforming growth factor β (TGFβ) receptors permits further analysis of the importance of the TGFβ family in intestinal biology. Expression of the type II TGFβ receptor was examined in gastrointestinal cell lines and tissues. The 5.5 kb type II mRNA species was detected in poly-(A) mRNA isolated from the rat small bowel and colon. Northern blot analysis of RNA isolated from epithelial and non-epithelial small intestinal cell fractions showed the majority of receptor mRNA localized in the non-epithelial compartment Immunohistochemical localization in the small intestine and colon supported the RNA findings; that is, expression was greatest in the lamina propria and muscularis. Staining was also detectable in the epithelium, where it was most prominent in the villus tip cells and absent in crypt cells. These findings mirror expression of TGFβ in the epithelial compartment The IEC-6, IPEC and RIE-1 cell lines, all of which are non-transformed, were growth inhibited by TGFβ and expressed type II receptor mRNA and protein. By contrast, the ras-trans-fected RIE-1, HT-29, Caco-2 and SW-620 transformed lines were not growth inhibited by TGFβ and all demonstrated a marked reduction in type II TGFβ receptor mRNA expression and protein abundance by cross-linking. In conclusion, (i) colocalization of both ligand and receptor establishes the existence of potential autocrine and/or paracrine pathways for TGFβ in the normal intestine and (ii) down-regulation of the type II TGFβ receptor occurs in association with cellular transformation and may contribute to intestinal carcinogenesis.

Journal Article.  0 words. 

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.